| Name |
Meglucon 500 mg tablete s produljenim oslobađanjem |
| Marketing Authorisation Number |
HR-H-665797041 |
| Active Substance |
metforminklorid |
| Composition |
jedna tableta s produljenim oslobađanjem sadrži 500 mg metforminklorida što odgovara 390 mg metformina |
| Pharmaceutical Form |
Tableta s produljenim oslobađanjem |
| Manufacturer |
Salutas Pharma GmbH, Barleben, Njemačka |
| Marketing Authorisation Holder |
Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date |
15.03.2023 |
| MA Period of Validity |
15.03.2028 |
| Classification Number |
UP/I-530-09/21-01/23 |
| Registration Number |
381-12-01/70-23-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ponovljivi recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
A10BA02 |
| Marketing status |
stavljeno u promet |
| Shortage status |
nema nestašice |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
